G01N 33/5756
Involving tumour-associated glycolinkage [tag]
Official title: {involving tumour-associated glycolinkage [TAG]}
G01N33/5756 (Involving tumour-associated glycolinkage [tag]) appears on 79 US grants and 59 published applications in this corpus.
Search patents in G01N- Granted patents
- 79
- Published applications
- 59
- Assignees
- 76
- Inventors
- 273
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 7 | 0 |
| 1989 | 5 | 0 |
| 1990 | 3 | 0 |
| 1991 | 6 | 0 |
| 1992 | 7 | 0 |
| 1993 | 3 | 0 |
| 1994 | 6 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 0 | 3 |
| 2007 | 0 | 3 |
| 2008 | 1 | 1 |
| 2009 | 1 | 2 |
| 2010 | 0 | 2 |
| 2011 | 1 | 2 |
| 2012 | 2 | 3 |
| 2013 | 0 | 1 |
| 2014 | 2 | 4 |
| 2015 | 0 | 1 |
| 2016 | 2 | 0 |
| 2017 | 3 | 1 |
| 2018 | 0 | 2 |
| 2019 | 0 | 6 |
| 2020 | 0 | 4 |
| 2021 | 4 | 6 |
| 2022 | 2 | 3 |
| 2023 | 0 | 1 |
| 2024 | 2 | 4 |
| 2025 | 2 | 6 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Multimeric proteins for detecting a carbohydrate and/or treating a siglec-mediated disorder25 Aug 2026US 12,715,903 B2Palleon Pharmaceuticals Inc.
- Glycoprotein biomarkers for esophageal adenocarcinoma and Barrett's esophagus and uses thereof16 Dec 2025US 12,498,373 B2The Council of the Queensland Institute of Medical Research
- Method of isolating and detecting cancer stem cells28 Oct 2025US 12,455,288 B2
- Method for isolating and detecting cancer stem cells8 Oct 2024US 12,109,248 B2
- Anti-glyco-MUC1 antibodies and their uses20 Aug 2024US 12,065,504 B2GO Therapeutics, Inc.
- Fusion protein20 Aug 2026US 2026/0242504 A1Ceinge Biotecnologie Avanzate Franco Salvatore Scarl
- Methods relating to tumour-derived extracellular vesicles16 Oct 2025US 2025/0321231 A1Inoviq Inc.
- Set of reagents for detecting a marker of epithelial carcinomas4 Sep 2025US 2025/0277792 A1Uct Research and Development Inc.
- Methods for detection of membrane bound glypican-313 Mar 2025US 2025/0085287 A1Adicet Therapeutics, Inc.
- Anti-glyco-muc1 antibodies and their uses6 Mar 2025US 2025/0075001 A1GO Therapeutics, Inc.
Most cited
By later US patents
- Antibodies to human carcinoma antigen83US 5,693,763 AEpigen, Inc. · 1997
- Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation71US 5,079,353 AChembiomed, Ltd. · 1992
- CMP-activated, fluorescing sialic acids, as well as processes for their preparation61US 5,405,753 A1995
- Human tumor-associated Thomsen-Friedenreich antigen52US 5,110,911 ABiomira, Inc. · 1992
- Human carcinoma antigen35US 5,808,005 AEpigen, Inc. · 1998